相关实验视频
Updated: Jan 11, 2026

05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
3.2K
氧向MYCN增强的神经母细胞瘤的向
Soraya Epp1, Donagh Egan1, Evon Poon2
1Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland.
Frontiers in oncology
|November 10, 2025
概括
针对线粒体新陈代谢的新疗法对高风险神经母细胞瘤 (HR-NB) 是有前途的. 化 (DPI) 和线基酸盐 (MitoQ) 协同作用,降低MYCN水平并提高MNA-NB中的化疗效果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 高危神经母细胞瘤 (HR-NB) 是一种致命的儿科癌症,其中一半是由MYCN基因放大 (MNA) 驱动的.
- 目前对MNA-NB的治疗包括高剂量的化疗,导致复发和严重的副作用,需要新的治疗策略.
- 针对MNA-NB细胞中的代谢脆弱性,为改善治疗结果提供了一个有希望的途径.
研究的目的:
- 研究一种针对MNA-NB细胞代谢漏洞的新型治疗方法.
- 在MNA-NB模型中评估化 (DPI) 和线素甲 (MitoQ) 的协同效应.
- 探索组合治疗对MYCN表达,细胞分化和与现有化疗药物的协同作用的影响.
主要方法:
- 利用神经母细胞瘤的2D和3D体外模型.
- 研究了DPI,一种黄蛋白和线粒体综合体I抑制剂,以及针对线粒体的抗氧化剂MitoQ的作用.
- 采用蛋白质组学和蛋白质组学分析来阐明药物作用机制.
主要成果:
- 在MNA-NB模型中,DPI和MitoQ显示出协同效应.
- 在低纳米度下,MitoQ显著降低了MYCN蛋白表达,并诱导了MNA细胞的分化.
- DPI和MitoQ的组合与标准NB化疗药物温克里斯协同作用,并通过细胞循环停止和抑制线粒体氧化酸化 (OXPHOS) 诱导细胞死亡.
结论:
- 干扰线粒体代谢是一种可行的策略,可以提高MNA-NB的化疗疗效率.
- DPI和MitoQ的组合为MNA-NB提供了一个潜在的新型治疗方法.
- 向线粒体通路可能会克服耐药性并减少与当前MNA-NB治疗相关的毒性.
更多相关视频
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

